Kronos Bio Stock Forecast for 2023 - 2025 - 2030

Updated on 05/03/2024

Stock Rating
2
Price Target
$4.25
Consensus
Outperform
Upside
312.62%
Analysts
0
Stock Rating
2
Upside
312.62%
Analysts
0
Price Target
$4.25

Kronos Bio Stock Forecast and Price Target

The average price target for Kronos Bio's stock of $4.25 recently provided by leading analysts would represent a 312.62% upside from its last closing price if reached. This potential increase is based on a high estimate of $6.00 and a low estimate of $2.50.

$4.25

312.62% Upside

Outperform
Outperform

Kronos Bio Fair Value Forecast for 2023 - 2025 - 2030

In the last two years, Kronos Bio's Price has seen an increase, rising from $0.00 to $0.00. This represents a growth of 100.00%. Analysts predict that Kronos Bio's Fair Value will increase in the upcoming year, reaching $0.00. This would represent an increase of 100.00%. Over the next six years, experts predict that Kronos Bio's Fair Value will grow at a rate of 100.00%.

2025 Fair Value Forecast
$0.00
2026 Fair Value Forecast
$0.00
2027 Fair Value Forecast
$0.00
2028 Fair Value Forecast
$0.00
2029 Fair Value Forecast
$0.00
2030 Fair Value Forecast
$0.00

Kronos Bio Revenue Forecast for 2023 - 2025 - 2030

Kronos Bio Dividend per Share Forecast for 2023 - 2025 - 2030

Kronos Bio Free Cash Flow Forecast for 2023 - 2025 - 2030

Kronos Bio EBITDA Forecast for 2023 - 2025 - 2030

Kronos Bio's EBITDA has grown in the last two years, jumping from $-57.21M to $-134.85M – an increase of 135.71%. 0 analysts predict Kronos Bio's EBITDA will decrease by 13.37% in the next year, reaching $-116.82M. By 2030, professionals predict that Kronos Bio's EBITDA will decrease by 12.24%, to $-118.34M.

2023 EBITDA Forecast
$-116820555.00
2024 EBITDA Forecast
$-103004577.36
2025 EBITDA Forecast
$-116614915.52
2026 EBITDA Forecast
$-123289175.85
2027 EBITDA Forecast
$-121780938.26
2028 EBITDA Forecast
$-115350904.72
2029 EBITDA Forecast
$-115889208.95
2030 EBITDA Forecast
$-118342197.20

Kronos Bio EBIT Forecast for 2023 - 2025 - 2030

In the last two years, Kronos Bio's EBIT has increased by 136.25%, going from $-58.04M to $-137.12M. For the following year, the 0 analysts predict that Kronos Bio's EBIT will drop by 13.61%, reaching $-118.45M. In 2030, the professionals' prediction is that KRON's EBIT will decrease by 12.45%, reaching $-120.05M.

2023 EBIT Forecast
$-118453397.33
2024 EBIT Forecast
$-104440360.43
2025 EBIT Forecast
$-118223006.66
2026 EBIT Forecast
$-125127230.25
2027 EBIT Forecast
$-123558968.96
2028 EBIT Forecast
$-117006224.98
2029 EBIT Forecast
$-117532752.99
2030 EBIT Forecast
$-120047953.90

Kronos Bio EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last two years, Kronos Bio's EPS has seen an increase, rising from $-2.37 to $0.00. This represents a growth of 100.00%. Analysts predict that Kronos Bio's EPS will increase in the upcoming year, reaching $0.00. This would represent an increase of 100.00%. Over the next six years, experts predict that Kronos Bio's EPS will grow at a rate of 100.00%.

2025 EPS Forecast
$0.00
2026 EPS Forecast
$0.00
2027 EPS Forecast
$0.00
2028 EPS Forecast
$0.00
2029 EPS Forecast
$0.00
2030 EPS Forecast
$0.00